Budur, K., Martenyi, F., Welsh-Bohmer, K. A., Burns, D. K., Chiang, C., O’Neil, J., … Roses, A. D. (2014). A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study. In Neuropsychopharmacology (Vol. 39, pp. S342–S342). Phoenix, AZ: NATURE PUBLISHING GROUP.

Budur, Kumar, Ferenc Martenyi, Kathleen A. Welsh-Bohmer, Daniel K. Burns, Carl Chiang, Janet O’Neil, Grant Runyan, et al. “A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study.” In Neuropsychopharmacology, 39:S342–S342. NATURE PUBLISHING GROUP, 2014.

Budur K, Martenyi F, Welsh-Bohmer KA, Burns DK, Chiang C, O’Neil J, et al. A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study. In: Neuropsychopharmacology. NATURE PUBLISHING GROUP; 2014. p. S342–S342.

Budur, Kumar, et al. “A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study.” Neuropsychopharmacology, vol. 39, NATURE PUBLISHING GROUP, 2014, pp. S342–S342.

Budur K, Martenyi F, Welsh-Bohmer KA, Burns DK, Chiang C, O’Neil J, Runyan G, Schuster J, Crenshaw DG, Lutz MW, Metz CA, Saunders AM, Yarbrough D, Yarnall D, Lai E, Brannan SK, Roses AD. A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study. Neuropsychopharmacology. NATURE PUBLISHING GROUP; 2014. p. S342–S342.